Literature DB >> 24147254

Historically significant events in the discovery of RANK/RANKL/OPG.

T John Martin1.   

Abstract

After it was suggested 30 years ago that the osteoblast lineage controlled the formation of osteoclasts, methods were developed that established this to be the case, but the molecular controls were elusive. Over more than a decade much evidence was obtained for signaling mechanisms that regulated the production of a membrane - bound regulator of osteoclastogenesis, in the course of which intercellular communication in bone was revealed in its complexity. The discovery of regulation by tumor necrosis factor ligand and receptor families was made in the last few years of the twentieth century, leading since then to a new physiology of bone, and to exciting drug development.

Entities:  

Keywords:  Bone biology; Osteoclasts; Osteoprotegerin; Receptor activator of nuclear factor κB; Receptor activator of nuclear factor κB ligand

Year:  2013        PMID: 24147254      PMCID: PMC3801238          DOI: 10.5312/wjo.v4.i4.186

Source DB:  PubMed          Journal:  World J Orthop        ISSN: 2218-5836


  87 in total

1.  Periosteal osteoclasts, skeletal development and ageing.

Authors:  E A TONNA
Journal:  Nature       Date:  1960-02-06       Impact factor: 49.962

2.  [Evaluation of metabolic profile tests using a computer].

Authors:  I Beseda; J Vál'ka
Journal:  Vet Med (Praha)       Date:  1977-12       Impact factor: 0.558

3.  Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis.

Authors:  E Tsuda; M Goto; S Mochizuki; K Yano; F Kobayashi; T Morinaga; K Higashio
Journal:  Biochem Biophys Res Commun       Date:  1997-05-08       Impact factor: 3.575

4.  Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization.

Authors:  G C Nicholson; J M Moseley; P M Sexton; F A Mendelsohn; T J Martin
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

5.  Studies on the adrenocorticotropic hormone-activated adenyl cyclase of a functional adrenal tumor.

Authors:  O D Taunton; J Roth; I Pastan
Journal:  J Biol Chem       Date:  1969-01-25       Impact factor: 5.157

6.  The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells.

Authors:  N Udagawa; N Takahashi; T Akatsu; T Sasaki; A Yamaguchi; H Kodama; T J Martin; T Suda
Journal:  Endocrinology       Date:  1989-10       Impact factor: 4.736

7.  Cloning of an osteoblastic cell line involved in the formation of osteoclast-like cells.

Authors:  T Yamashita; K Asano; N Takahashi; T Akatsu; N Udagawa; T Sasaki; T J Martin; T Suda
Journal:  J Cell Physiol       Date:  1990-12       Impact factor: 6.384

8.  Rat osteogenic sarcoma cells:effects of some prostaglandins, their metabolites and analogues on cyclic AMP production.

Authors:  D Atkins; T J Martin
Journal:  Prostaglandins       Date:  1977-05

9.  Bone cells predispose bone surfaces to resorption by exposure of mineral to osteoclastic contact.

Authors:  T J Chambers; K Fuller
Journal:  J Cell Sci       Date:  1985-06       Impact factor: 5.285

10.  TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor.

Authors:  B R Wong; R Josien; S Y Lee; B Sauter; H L Li; R M Steinman; Y Choi
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

View more
  24 in total

Review 1.  Osteoprotegerin and kidney disease.

Authors:  Alejandra Montañez-Barragán; Isaias Gómez-Barrera; Maria D Sanchez-Niño; Alvaro C Ucero; Liliana González-Espinoza; Alberto Ortiz
Journal:  J Nephrol       Date:  2014-04-23       Impact factor: 3.902

2.  Regulators of G protein signaling 12 promotes osteoclastogenesis in bone remodeling and pathological bone loss.

Authors:  X Yuan; J Cao; T Liu; Y-P Li; F Scannapieco; X He; M J Oursler; X Zhang; J Vacher; C Li; D Olson; S Yang
Journal:  Cell Death Differ       Date:  2015-04-24       Impact factor: 15.828

Review 3.  Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond.

Authors:  Maria V Deligiorgi; Mihalis I Panayiotidis; John Griniatsos; Dimitrios T Trafalis
Journal:  Clin Exp Metastasis       Date:  2019-10-01       Impact factor: 5.150

4.  Mutual enhancement of differentiation of osteoblasts and osteocytes occurs through direct cell-cell contact.

Authors:  Koji Fujita; Qian Xing; Sundeep Khosla; David G Monroe
Journal:  J Cell Biochem       Date:  2014-11       Impact factor: 4.429

5.  OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism.

Authors:  Laleh Ardeshirpour; Cristina Dumitru; Pamela Dann; John Sterpka; Joshua VanHouten; Wonnam Kim; Paul Kostenuik; John Wysolmerski
Journal:  Endocrinology       Date:  2015-05-11       Impact factor: 4.736

6.  Effect of r-Mt-Cpn10 on human osteoblast cells.

Authors:  Yuanyu Zhang; Xia Liu; Kun Li; Jingping Bai
Journal:  Int J Clin Exp Med       Date:  2014-09-15

Review 7.  MicroRNAs in the control of metastatic bone disease.

Authors:  Gillian Browne; Hanna Taipaleenmäki; Gary S Stein; Janet L Stein; Jane B Lian
Journal:  Trends Endocrinol Metab       Date:  2014-05-05       Impact factor: 12.015

8.  Increased receptor activator of nuclear factor κβ ligand/osteoprotegerin ratio exacerbates cartilage destruction in osteoarthritis in vitro.

Authors:  Ji-Zhou Zeng; Zhen-Zhong Wang; Li-Feng Ma; Hai Meng; Hao-Miao Yu; Wen-Hao Cheng; Ya-Kui Zhang; Ai Guo
Journal:  Exp Ther Med       Date:  2016-08-31       Impact factor: 2.447

9.  Histochemical examination of the effects of high-dose 1,25(OH)2D3 on bone remodeling in young growing rats.

Authors:  Jing Sun; Bao Sun; Wei Wang; Xiuchun Han; Hongrui Liu; Juan Du; Wei Feng; Bo Liu; Norio Amizuka; Minqi Li
Journal:  J Mol Histol       Date:  2016-06-02       Impact factor: 2.611

10.  Oral Mucosal Lamina Propria-Progenitor Cells Exert Antibacterial Properties via the Secretion of Osteoprotegerin and Haptoglobin.

Authors:  Emma Board-Davies; Rachael Moses; Alastair Sloan; Phil Stephens; Lindsay C Davies
Journal:  Stem Cells Transl Med       Date:  2015-09-16       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.